Theratechnologies Inc T.TH

Info on Meeting vis Truist today

[SPCEO1]

I am not seeing any notification of a Truist report yet on Bloomberg.



10/18/2022 07:15:06 [BN] Bloomberg News

Theratechnologies at Non-Deal Roadshow Hosted By Truist Today

By Bloomberg Automation

Truist is hosting a corporate access non-deal roadshow for Theratechnologies Inc. in New York

today.

WeConvene provided the following details:

==============================================

Title: Theratechnologies, Inc. (THTX) - Non Deal Roadshow

Summary: Truist analyst Robyn Karnauskas will host a Non-Deal Roadshow with the CEO; SVP/CFO; SVP/CMO; SD,

IR of Theratechnologies, Inc on October 18, 2022 in New York. (In Person)

Management/Speakers:

Robyn Karnauskas, Biotechnology Analyst

Host Contacts:

Robin Mann, [e-mail]

==============================================

Analyst price targets for Theratechnologies range from C$3.25 to C$8.53, with a consensus average of

C$4.91.

Theratechnologies has 1 buy recommendation, 3 holds and 0 sells

Market cap - C$263.5 million

Short interest - 172,649 shares, representing 0.2 percent of the total float and 2.7 days average trading

volume as of the latest data

The Relative Strength Index (RSI) indicates the company is neither overbought nor oversold

Shares of the company fell 3.1 percent in the last session to C$2.77 and are down 27.5 percent this year

[Wino115]

Interesting. A few thoughts. 1. She seems pretty well qualified - BA @MIT, Doctoral @ U Chicago.  Analyst at Deutsche, Citibank and now Truist. Decent rank on "successful" calls from the puplic sites I saw. Would make a nice analyst addition if it ever comes to be. 2. Normally these kind of meetings require a big push by sales people to engage their top biotech or small cap

[Biobob]

Also, maybe just maybe they are keeping bits of new info just for their potential new investors... to make shure they get in on the action.  Hey it's capitalism...